Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event

Rhea-AI Summary

Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT), a clinical-stage pharmaceutical company specializing in cancer drug development, is set to participate in the Q3 Investor Summit on August 20th, 2024. The event, focused on 50 micro-cap companies with catalysts or strong market performance, will feature Lixte's presentation at 2:00 pm ET.

Investors can access the presentation via a live webcast. Throughout the day, Lixte will also be available for one-on-one meetings with interested parties. This summit provides an opportunity for qualified investors to engage with promising micro-cap companies, offering live Q&A sessions and in-depth discussions.

NEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.

Event: Q3 Investor Summit
Date: August 20^th, 2024
Presentation Time: 2:00 pm ET
Location: https://www.webcaster4.com/Webcast/Page/3062/51117

• The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.

• Take a deep dive with the best Investors in MicroCap

• Live Q & A

• Complimentary to Qualified Investors. Please REGISTER HERE.

About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.

Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group

SOURCE: Lixte Biotechnology Holdings, Inc.

View the original press release on accesswire.com

FAQ

When is Lixte Biotechnology Holdings (LIXT) presenting at the Q3 Investor Summit?

Lixte Biotechnology Holdings (LIXT) is presenting at the Q3 Investor Summit on August 20th, 2024, at 2:00 pm ET.

What is the focus of Lixte Biotechnology Holdings (LIXT)?

Lixte Biotechnology Holdings (LIXT) is a clinical-stage pharmaceutical company focused on developing new targets for cancer drug development and commercializing cancer therapies.

How can investors access Lixte Biotechnology's (LIXT) presentation at the Q3 Investor Summit?

Investors can access Lixte Biotechnology's (LIXT) presentation via a live webcast at https://www.webcaster4.com/Webcast/Page/3062/51117.

Will Lixte Biotechnology (LIXT) be available for one-on-one meetings at the Q3 Investor Summit?

Yes, Lixte Biotechnology (LIXT) will be available for one-on-one meetings throughout the day of the Q3 Investor Summit on August 20th, 2024.

What is the theme of the Q3 Investor Summit featuring Lixte Biotechnology (LIXT)?

The theme of the Q3 Investor Summit is 50 micro-cap companies with a catalyst and/or strong performance in the current market.